Four-year Follow-up of the SYNTAX Trial: Optimal Revascularization Strategy in Patients with Three-vessel Disease and/or Left Main Disease
Presenter: David R. Holmes
Up Next
Presenter: Alexander Sheehy
More slides +
Presenter: Stephen W. Lee
Presenter: Piotr P. Buszman